TEVA PHARMACEUTICAL INDUSTRIES LTD Earnings Per Share Diluted

• TEVA PHARMACEUTICAL INDUSTRIES LTD showed an increase of +183.4% in Earnings Per Share Diluted from 2024 to 2025.
• This data is from TEVA PHARMACEUTICAL INDUSTRIES LTD's annual report (Form 10-K), filed with the SEC on February 3, 2026.
• XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q1 2016: $0.62 per share | Q2 2016: $0.20 per share | Q3 2016: $0.35 per share | Q4 2016: $1.02 (loss) per share | Q1 2017: $0.57 per share | Q2 2017: $5.94 (loss) per share | Q3 2017: $0.52 per share | Q4 2017: $11.41 (loss) per share | Q1 2018: $1.03 per share | Q2 2018: $0.24 (loss) per share | Q3 2018: $0.27 (loss) per share | Q4 2018: $2.85 (loss) per share | Q1 2019: $0.10 (loss) per share | Q2 2019: $0.63 (loss) per share | Q3 2019: $0.29 (loss) per share | Q4 2019: $0.10 per share | Q1 2020: $0.06 per share | Q2 2020: $0.13 per share | Q3 2020: $3.97 (loss) per share | Q4 2020: $0.14 per share | Q1 2021: $0.07 per share | Q2 2021: $0.19 per share | Q3 2021: $0.26 per share | Q1 2022: $0.86 (loss) per share | Q2 2022: $0.23 (loss) per share | Q3 2022: $0.05 per share | Q4 2022: $1.17 (loss) per share | Q1 2023: $0.20 (loss) per share | Q2 2023: $0.78 (loss) per share | Q3 2023: $0.06 per share | Q1 2024: $0.12 (loss) per share | Q2 2024: $0.75 (loss) per share | Q3 2024: $0.39 (loss) per share | Q1 2025: $0.18 per share | Q2 2025: $0.24 per share | Q3 2025: $0.37 per share.
• Over the full 18 years of available data (2008 to 2025), TEVA PHARMACEUTICAL INDUSTRIES LTD's Earnings Per Share Diluted has grown by 61.3%.
• Historical annual values: Fiscal year 2025: $1.21 per share | Fiscal year 2024: $1.45 (loss) per share | Fiscal year 2023: $0.50 (loss) per share | Fiscal year 2022: $2.20 (loss) per share | Fiscal year 2021: $0.38 per share | Fiscal year 2020: $3.64 (loss) per share | Fiscal year 2019: $0.91 (loss) per share | Fiscal year 2018: $2.35 (loss) per share | Fiscal year 2017: $16.26 (loss) per share | Fiscal year 2016: $0.07 per share | Fiscal year 2015: $1.82 per share | Fiscal year 2014: $3.56 per share | Fiscal year 2013: $1.49 per share | Fiscal year 2012: $2.25 per share | Fiscal year 2011: $3.09 per share | Fiscal year 2010: $3.67 per share | Fiscal year 2009: $2.23 per share | Fiscal year 2008: $0.75 per share.
• Data sourced from SEC EDGAR public filings as of August 5, 2026.

Last verified: August 5, 2026